#24: FastFun: IMPAX Submits Additional Information to FDA Related to ANDA For Generic Version of Opana(R) ER
IMPAX Laboratories, Inc. (OTC:IPXL) today announced that it has... |
December 8, 2007
06:31:28 AM |
#23: FastFun: IMPAX to Reinitiate Sales of Limited Quantity of Generic OxyContin(R)
IMPAX Laboratories, Inc. (OTC:IPXL) today announced that its distributor... |
December 8, 2007
06:31:00 AM |
#22: NewsBot: IPXL News IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
April 2, 2007
08:00:00 AM |
#21: NewsBot: IPXL News IMPAX to Present at the Lehman Brothers 10th Annual Global Healthcare Conference
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
March 14, 2007
05:00:00 AM |
#20: NewsBot: IPXL News IMPAX Settles Patent Litigation Related to Generic Wellbutrin(R) XL
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL)... |
March 5, 2007
05:27:00 AM |
#19: NewsBot: IPXL News IMPAX Files Amendment to Vadova(TM) NDA
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
January 18, 2007
05:00:00 AM |
#18: NewsBot: IPXL News IMPAX Reports SEC Actions
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL)... |
January 2, 2007
02:25:00 PM |
#17: NewsBot: IPXL News IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC: IPXL)... |
December 18, 2006
05:00:00 AM |
#16: NewsBot: IPXL News IMPAX Announces Court of Appeals Remands Earlier Riluzole Patent Validity Decision Back to Lower Court
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC: IPXL)... |
November 22, 2006
05:31:00 AM |
#15: NewsBot: IPXL News IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
November 10, 2006
07:41:00 AM |
#14: NewsBot: IPXL News IMPAX Appoints Grant Thornton as Principal Accountant
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
November 9, 2006
05:53:00 AM |
#13: NewsBot: IPXL News IMPAX Receives FDA Approval for Generic Versions of Urecholine(R) Tablets
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
November 3, 2006
05:43:00 AM |
#12: NewsBot: IPXL News IMPAX Receives FDA Approval for Generic Version of Colestid(R) Tablets
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
October 26, 2006
05:59:00 AM |
#11: NewsBot: IPXL News IMPAX Announces Dismissal of Lawsuit Related to Generic Concerta(R)
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) today... |
October 3, 2006
06:16:00 AM |
#10: NewsBot: IPXL News IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
HAYWARD, Calif.--(BUSINESS WIRE)--Sept. 7, 2006--IMPAX Laboratories, Inc.... |
September 7, 2006
04:00:00 AM |
| 
| 
| 
| 
| 
| 
